BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 287 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $18,770,000 | -13.7% | 158,301 | +0.3% | 0.38% | -18.1% |
Q4 2021 | $21,751,000 | +36.9% | 157,835 | +38.0% | 0.46% | +61.1% |
Q3 2021 | $15,884,000 | -63.2% | 114,345 | -74.3% | 0.29% | -59.7% |
Q2 2021 | $43,172,000 | +37.7% | 444,701 | -3.0% | 0.71% | +34.5% |
Q1 2021 | $31,345,000 | +396.8% | 458,600 | +372.6% | 0.53% | +168.2% |
Q3 2020 | $6,309,000 | -28.3% | 97,047 | -19.4% | 0.20% | -18.5% |
Q2 2020 | $8,797,000 | – | 120,332 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |